Antibiotics combination therapy in patients with active ulcerative colitis: a double-blind placebo-controlled multicenter trial

被引：0

作者：

Ohkusa, Toshifumi ^{[1
]}

Kato, Kimitoshi ^{[2
]}

Terao, Shuichi ^{[2
]}

Chiba, Toshimi ^{[2
]}

Mabe, Katsuhiro ^{[2
]}

Murakami, Kazunari ^{[2
]}

Mizokami, Yuji ^{[2
]}

Takeuchi, Yoshiaki ^{[2
]}

Sugiyama, Toshiro ^{[2
]}

Kudo, Takahiko ^{[2
]}

Yanaka, Akinori ^{[2
]}

Yamato, Shigeru ^{[2
]}

Yokoyama, Tetsuji ^{[2
]}

Okayasu, Isao ^{[2
]}

Sato, Nobuhiro ^{[1
]}

Watanabe, Sumio ^{[1
]}

机构：

[1] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan

[2] Japan UC Antibiot Therapy Study Grp, Tokyo, Japan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A179 / A179

页数：1

共 50 条

[31] Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients
Eberhardson, Michael
Karlen, Per
Linton, Ludvig
Jones, Petra
Lindberg, Annelie
Kostalla, Martina Jones
Lindh, Emma
Oden, Anders
Glise, Hans
Winqvist, Ola
JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 534 - 542
[32] Curcumin, a promising drug for long-term maintenance therapy in patients with ulcerative colitis: Results from a multicenter, randomized double-blind placebo-controlled clinical trial
Hanai, Hiroyuki
Iida, Takayuki
Takeuchi, Ken
Yamada, Masarm
Iwaoka, Yasushi
Andoh, Akira
Tujikawa, Tomoyuki
Fujiyama, Yoshihide
Watanabe, Furmtoslu
Maruyama, Yasuhiko
Mitsuyama, Keiichi
Sata, Michio
Kanke, Kazunari
Hiraishi, Hideyuki
Hirayama, Kazuhisa
Arai, Hajime
Yoshii, Shigehitc
Uchijima, Masato
Nagata, Toshi
Koide, Yukio
GASTROENTEROLOGY, 2006, 130 (04) : A84 - A84
[33] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
Levin, B
Thompson, JLP
Levy, G
Mitsumoto, H
Kaufmann, P
NEUROLOGY, 2006, 66 (11) : 1786 - 1786
[34] Cabergoline in advanced RLS: A double-blind, placebo-controlled, multicenter trial
Stiasny-Kolster, K
Ueberall, M
Oertel, W
MOVEMENT DISORDERS, 2002, 17 : S231 - S231
[35] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
Meininger, V
Asselain, B
Guillet, P
Leigh, PN
Ludolph, A
Lacomblez, L
Robberecht, W
NEUROLOGY, 2006, 66 (01) : 88 - 92
[36] Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial
Gionchetti, P
Rizzello, F
Ferrieri, A
Venturi, A
Brignola, C
Ferretti, M
Peruzzo, S
Miglioli, M
Campieri, M
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (06) : 1220 - 1221
[37] A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor
Jankovic, J
Ondo, WG
Stacy, MA
Elble, RJ
Pahwa, R
Connor, GS
Hulihan, JF
Schwarzman, L
Wu, SC
MOVEMENT DISORDERS, 2004, 19 : S448 - S449
[38] Randomised, double-blind, placebo-controlled trial of oral aloe vera gel for mild-moderately active ulcerative colitis
Langmead, L
Feakins, R
Goldthorpe, S
Tsironi, E
de Silva, A
Jewell, D
Rampton, D
GASTROENTEROLOGY, 2004, 126 (04) : A463 - A463
[39] Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, Multicenter Trial of Budesonide and Mesalamine in Collagenous Colitis
Miehlke, Stephan
Madisch, Ahmed
Kupcinskas, Limas
Heptner, Gerhard
Boehm, Guenter
Marks, Hans-Joachim A.
Neumeyer, Michael
Nathan, Torben
Fernandez-Banares, Fernando
Greinwald, Roland
Mohrbacher, Ralf
Vieth, Michael
Bonderup, Ole K.
GASTROENTEROLOGY, 2012, 142 (05) : S211 - S211
[40] Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial
Ben-Horin, S.
Salomon, N.
Karampekos, G.
Viazis, N.
Lahat, A.
Ungar, B.
Eliakim, R.
Kriger-Sharabi, O.
Reiss-Mintz, H.
Yanai, H.
Dotan, I.
Zittan, E.
Maharshak, N.
Hirsch, A.
Weitman, M.
Mantzaris, G. J.
Kopylov, U.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 691 - 691

← 1 2 3 4 5 →